Evaluation of Safety and Tolerability of Libella Gene Therapy for Alzheimer's Disease: AAV- hTERT

Clinical trial NCT04133454 · UNKNOWN

Trial details

NCT number: NCT04133454
Sponsor: Libella Gene Therapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2019-10-10
Primary completion: 2021-01-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.